drugset / Trial / NCT03036085

Liposomal Bupivacaine for Pain Control Following Thoracic Surgery.

NCT03036085

Phase 2/3 Unknown 200 enrolled Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The aims of the study are to compare the effectiveness and postoperative outcomes of liposomal bupivacaine vs plain bupivacaine following video-assisted thoracoscopic surgery. The investigators' hypothesis is that liposomal bupivacaine will decrease the postoperative pain and will be associated with more favorable postoperative outcomes when compared to plain bupivacaine following video-assisted thoracoscopic surgery.

Timeline

Start
2017-02
Primary completion
2017-12
Completion
2017-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 266 mg Other
Comparator Epinephrine Other / unclassified Other